Merck leans on a fast-growing pipeline and new product launches to aid long-term growth as Keytruda's 2028 LOE nears.

Being thin does not shield your heart from trouble. Slim people often carry high cholesterol that builds up in arteries year ...

India’s first new antibiotic in 30 years. A powerful oral cholesterol-lowering pill showed promise, China claimed a longevity ...

Sperm from a donor who unknowingly carried a cancer gene has been used to conceive almost 200 babies in Europe, according to ...

Armed with positive results in two phase 3 trials, MSD is poised to be the first drugmaker to file for approval of an oral PCSK9 inhibitor for lowering cholesterol. Top-line results from the CORALreef ...

Heart doctors are capturing images of the inside of heart arteries, helping them watch plaque respond to cholesterol drugs in ...

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') announced the successful inclusion of all five of the Company's self-developed innovative drugs into the updated National Reimbursement Drug List (NRDL ...

Panelists discuss how PCSK9 inhibitors remain underused due to access, cost, and adherence barriers.

(HealthDay News) — Exome sequencing can identify individuals who are genotype-positive for familial hypercholesterolemia (FH), according to a study published online Nov. 12 in Circulation: Genomic and ...

Patients with statin resistance do not experience symptoms, Le noted. Instead, the problem is that statins do not lower LDL-C levels as much as they typically do. Instead of a 50% reduction, people ...

A one-off shot of a new drug could cut high cholesterol levels for life. The 'game-changing' drug works by switching off a ...